LRMR
Larimar Therapeutics, Inc.
There isn't enough reported data to score LRMR yet.
LRMR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
LRMR's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LRMR PE Valuation
LRMR has no meaningful PE right now: it lost money over the past year.
LRMR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Moderate |
Analysts expect LRMR's losses to shrink, with revenue holding steady.
LRMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$1.95 | -$0.81 |
| Q2 2025 | -$1.58 | -$0.47 |
| Q1 2025 | -$1.51 | -$0.55 |
| Q4 2024 | -$1.32 | -$0.48 |
| Q3 2022 | -$1.81 | +$2.28 |
| Q2 2022 | -$2.36 | +$1.45 |
| Q1 2022 | -$2.68 | +$1.55 |
| Q4 2021 | -$2.95 | +$1.72 |
LRMR is still losing money, but far less than before: $1.95 per share over the past year, against $16.92 at its worst in late 2019.
LRMR Quarterly Revenue
LRMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2025 | -$26.6M | -$16.2M |
| Q1 2024 | -$10.4M | -$2.9M |
| Q1 2023 | -$7.6M | -$18K |
| Q4 2022 | -$6.7M | +$1.3M |
| Q3 2022 | -$5.9M | +$6.6M |
| Q4 2021 | -$7.9M | +$1.9M |
| Q3 2021 | -$12.5M | -$1.3M |
| Q4 2020 | -$9.9M | +$235K |
LRMR has burned cash in almost every quarter: −$93M over the past year, against −$31M the year before.
LRMR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +62% | +39.9M shares |
| 3 years | +137% | +60M shares |
| 5 years | +550% | +87.9M shares |
| Available history | +3236% | +101M shares |
LRMR has 104M diluted shares, up 62% from a year ago.
LRMR Net Leverage
LRMR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LRMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 23.7 | Neutral |
LRMR's weekly RSI is 42 (neutral) and its Stochastic is 24 (neutral).
LRMR PE vs Healthcare Sector
LRMR has no meaningful PE right now: it lost money over the past year.
LRMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.58 | 4.7% above |
| 20 week MA | $3.40 | 21% below |
| 50 week MA | $3.71 | 27% below |
| 100 week MA | $3.51 | 23% below |
| 200 week MA | $4.71 | 43% below |
LRMR has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 43% below its 200-week average.
LRMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $22.1 | +59% |
| 2021 | $22.1 | $10.6 | -52% |
| 2022 | $10.6 | $4.36 | -59% |
| 2023 | $4.36 | $4.55 | +4.4% |
| 2024 | $4.55 | $3.96 | -13% |
| 2025 | $3.96 | $3.93 | -0.8% |
| 2026 YTD | $3.93 | $2.70 | -31% |
LRMR has finished lower in four of the last six years. It's down 31% so far in 2026.